INI-CET EXAM -2025
Obstetrics & Gynaecology
Easy

Which of the following is NOT a test of ovarian reserve during the early follicular phase?

Appeared in: INI-CET EXAM -2025

Explanation

  • Anti-Müllerian Hormone (AMH) is a key hormone for assessing ovarian reserve, as it is produced by the granulosa cells of small, growing follicles.
  • The primary advantage of AMH testing is that its levels are relatively stable and consistent throughout the menstrual cycle.
  • Because AMH is not dependent on the cycle stage, it can be measured on any day, unlike other markers that must be timed to the early follicular phase.
  • This cycle independence makes AMH a convenient and reliable marker for the remaining egg supply.

Why Other Options Were Wrong

  • Option A: Basal Follicle-Stimulating Hormone (FSH) level is a standard test for ovarian reserve that is specifically measured in the early follicular phase (days 2-4 of the menstrual cycle).
  • Option B: Estradiol (E2) levels are measured along with FSH in the early follicular phase (days 2-4) to help interpret the FSH results and provide a more complete picture of ovarian function.
  • Option D: Antral Follicle Count (AFC) is a transvaginal ultrasound examination performed in the early follicular phase to count the number of small, resting follicles, which directly relates to ovarian reserve.

Related Visual

Visual explanation — Related Visual
  • Visual 1: Diagram - A chart showing the hormonal fluctuations (FSH, LH, Estrogen, Progesterone) throughout the menstrual cycle, highlighting the early follicular phase.
  • Visual 2: Ultrasound Image - A transvaginal ultrasound image showing multiple small, dark circles within the ovary, illustrating what is counted during an Antral Follicle Count (AFC).
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Ovarian reserve testing as background academic context rather than a clinical decision trigger.
  • Assessing ovarian reserve is a critical step in fertility evaluation, helping to guide treatment decisions, predict response to ovarian stimulation for procedures like IVF, and counsel patients on their reproductive potential.
  • For nurses in fertility clinics, understanding the timing and significance of these tests is essential for patient education, scheduling appointments correctly, and interpreting results for the clinical team.
  • What if? If a patient has highly irregular or absent menstrual cycles, AMH testing becomes particularly valuable because it does not require timing to a specific cycle day, unlike FSH, E2, and AFC.
How to Approach the Question
  • First, identify the keywords in the question: "NOT," "test of ovarian reserve," and "early follicular phase."
  • The word "NOT" is crucial; you are looking for the exception among the options.
  • Review each option and recall or determine its specific role and timing in ovarian reserve testing.
  • Evaluate FSH: This is a classic day 3 test.
  • Evaluate E2: This is also a day 3 test, usually done with FSH.
  • Evaluate AFC: This is an ultrasound done in the early part of the cycle.
Concept Tested & Keywords
  • Concept Tested: Ovarian reserve testing
  • Stem keywords: ovarian reserve, early follicular phase, test
  • Lead-in keywords: NOT
  • Negative lead-in flag: The question asks to identify the option that is NOT a test for ovarian reserve specifically performed during the early follicular phase.

Question ID

QgvHSQQFKNW0GQo-PYkT7O

Practise the full INI-CET EXAM -2025

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Infertility Questions

More INI-CET EXAM -2025 Questions